Stockreport

This Small Biotech Stock Is Surging Today. Here's Why. [Yahoo! Finance]

Tourmaline Bio, Inc.  (TRML) 
PDF KEY TAKEAWAYS Novartis said Tuesday it is buying Tourmaline Bio for $1.4 billion, in a deal that gives the Swiss pharma giant access to the biotech's late-stage cardi [Read more]